A new outlook on type 1 diabetes

For the 300,000 Canadians living with type 1 diabetes (an autoimmune condition where the pancreas stops producing insulin), consistent monitoring of glucose levels and lifelong insulin injections are required to survive. However, innovations in diabetes management like Continuous Glucose Monitoring (CGM) mean that a type 1 diagnosis no longer needs to be something daunting or uncontrollable.

For example, Continuous Glucose Monitoring technology is changing the lives of people like Stephanie Brodie.

At the age of 14, Brodie was looking forward to playing rep hockey and making new friends in high school. But just before her birthday, she was diagnosed with type 1 diabetes. She began the regimen of multiple daily insulin injections and grew obsessive over her ability to control her blood glucose levels, pricking her fingers upwards of 10 times a day. But since so many factors impact glucose variability, she found herself overly frustrated and consumed by fear.

When Brodie switched to a Dexcom G5 Mobile Continuous Glucose Monitoring System, she began to take back control of her life. With the ability to monitor her glucose levels simply with a glance at her phone or smartwatch, she gained greater visibility and control over her condition. With this technology, she could see not only her glucose number but also the direction and rate of change, critical information for making optimal insulin dosing decisions to keep her glucose in range.

An active fitness professional and outdoor adventure enthusiast, Brodie can now enjoy the things she has always dreamed of doing – like taking on a hiking trip from Alaska to BC.

“Dexcom gave me more confidence and peace of mind. It’s made life simpler and a lot less stressful,” she says.

 


 

Help Erie Media stay online with a voluntary subscription


Subscription Options